| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 7 | |
| #2 | Australia | 4 | |
| #3 | EPO (European Patent Office) | 4 | |
| #4 | WIPO (World Intellectual Property Organization) | 4 | |
| #5 | Canada | 2 | |
| #6 | Mexico | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Sugars | |
| #4 | Special acyclic compounds | |
| #5 | Unspecified technologies | |
| #6 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Hostetler Karl Y | 23 |
| #2 | Beadle James R | 6 |
| #3 | Kini Ganesh D | 3 |
| #4 | Ruiz Jacqueline C | 1 |
| #5 | Choo Hyunah | 1 |
| #6 | Wan W Brad | 1 |
| #7 | Ganesh D Kini Ph D | 1 |
| #8 | Mellors John W | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2009215726A1 | Phosphono-pent-2-en-1-yl nucleosides and analogs | |
| WO0147511A2 | Treatment of drug-resistant human immunodeficiency virus infection | |
| EP0831794A1 | Acyclovir derivatives for topical use | |
| EP0831855A1 | Nucleotide analogues for topical treatment of proliferative disease of the skin | |
| US5696277A | Antiviral prodrugs | |
| AU4372193A | Acyclovir derivatives for topical use |